Identification of aldolase A as a potential diagnostic biomarker for colorectal cancer based on proteomic analysis using formalin-fixed paraffin-embedded tissue-Reference-Cited by-同舟云学术

Identification of aldolase A as a potential diagnostic biomarker for colorectal cancer based on proteomic analysis using formalin-fixed paraffin-embedded tissue

Published:2016-07-28 Issue:10 Volume:37 Page:13595-13606
ISSN:1010-4283
Container-title:Tumor Biology
language:en
Short-container-title:Tumor Biol.

Author:

Yamamoto Tetsushi,Kudo Mitsuhiro,Peng Wei-Xia,Takata Hideyuki,Takakura Hideki,Teduka Kiyoshi,Fujii Takenori,Mitamura Kuniko,Taga Atsushi,Uchida Eiji,Naito Zenya

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s13277-016-5275-8.pdf

Reference42 articles.

1. Kuusela P, Jalanko H, Roberts P, Sipponen P, Mecklin JP, Pitkanen R, Makela O. Comparison of CA 19-9 and carcinoembryonic antigen (CEA) levels in the serum of patients with colorectal diseases. Br J Cancer. 1984;49:135–9.

2. Zamcheck N, Pusztaszeri G. CEA, AFP and other potential tumor markers. CA Cancer J Clin. 1975;25:204–14.

3. Shi SR, Cote RJ, Taylor CR. Antigen retrieval immunohistochemistry: past, present, and future. The journal of histochemistry and cytochemistry: official journal of the Histochemistry Society. 1997;45:327–43.

4. Tourtellotte WW, Verity AN, Schmid P, Martinez S, Shapshak P. Covalent binding of formalin fixed paraffin embedded brain tissue sections to glass slides suitable for in situ hybridization. J Virol Methods. 1987;15:87–99.

5. Zhao J, Wu R, Au A, Marquez A, Yu Y, Shi Z. Determination of HER2 gene amplification by chromogenic in situ hybridization (CISH) in archival breast carcinoma. Modern pathology: an official journal of the United States and Canadian Academy of Pathology, Inc. 2002;15:657–65.

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diverse roles of aldolase enzymes in cancer development, drug resistance and therapeutic approaches as moonlighting enzymes;Medical Oncology;2024-08-09

2. Biomarker Identification through Proteomics in Colorectal Cancer;International Journal of Molecular Sciences;2024-02-14

3. Current Trends in the Biomarker'sDiscovery for the Treatment and Management of Colorectal Cancer: A ComprehensiveReview;Current Medicinal Chemistry;2024-01-31

4. Cyclophilin A: An Independent Prognostic Factor for Survival in Patients with Metastatic Colorectal Cancer Treated with Bevacizumab and Chemotherapy;Cancers;2024-01-16

5. An Updated Review on Molecular Biomarkers in Diagnosis and Therapy of Colorectal Cancer;Current Cancer Drug Targets;2023-11-29